Skip to content

Chromium Picolinate and Obesity

Effect of Chromium Picolinate supplementation on weight, fat mass and Leptin serum in obese and overweight peopel

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014012210826N6
Enrollment
100
Registered
2014-01-29
Start date
2013-05-05
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity. Obesity, unspecified

Interventions

Intervention 1: In intrvention group, obese or overweight individuals, aged 20 to 50, will recieve a daily 200 mcg Chromium Picolinat and do 30 minutes exercise. The subjects are told not to change di
Treatment - Drugs
In intrvention group, obese or overweight individuals, aged 20 to 50, will recieve a daily 200 mcg Chromium Picolinat and do 30 minutes exercise. The subjects are told not to change diet and life styl
In control group, obese and overweight individuals, aged 20-50 years, will recieve no intervention. The subjects are told not to change diet and life style.

Sponsors

Shahid Sadoughi University of Medical Science,International branch
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Body mass index (BMI) over 25 Kg / m2; men and women aged 20 to 50 years old; without diabetes, CVD; didn't heart surgery; lack of menopause; non smoking status; inactive (based on questionnaires) and willing to participate in study. Exclusion criteria: don't use more than 20% drug that they have; unwillingness to do exercise; specific disease during study; smoking during study; menopause.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Weight. Timepoint: Before intervention and once a month after. Method of measurement: Scale with accuracy 100 gr.;Body Mass Index (BMI). Timepoint: Before intervention and then once a month after. Method of measurement: Calculation: Weight (kg) / squared height (m).;Waist. Timepoint: Before intervention and then once a month after. Method of measurement: Tape meter.;Body Fat Mass. Timepoint: Before intervention and once a month after. Method of measurement: Body Composition Instrument.;Serum leptin levels. Timepoint: Before and after intervation. Method of measurement: ELISA kit.

Secondary

MeasureTime frame
Height. Timepoint: Before intervention and then once a month after. Method of measurement: Tape meter instaled on the wall.;Total energy intake. Timepoint: Before and after intervention. Method of measurement: 24 hour recall.;Total charbohydate intake. Timepoint: Before and after intervention. Method of measurement: 24 hour recall.;Total fat intake. Timepoint: Before and after intervention. Method of measurement: 24 hour recall.;Total protein intake. Timepoint: Bafore and after intervention. Method of measurement: 24 hour recall.;Total Chromium intake. Timepoint: Bafore and after intervention. Method of measurement: 24 hour recall.

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026